SAVING LIVES:
By adding SonoCiné to our practice, my hope was that in the first 1000 women with dense breasts screened with normal mammograms we would find 3 cancers missed on mammograms. In fact, we found our first cancer after only 70 cases and our second cancer after case number 100.
Nearly 20 years ago, I realized that early detection of invasive breast cancer in women with dense breast tissue would avoid the ravages of both the disease and the effects of its treatment. Since then, my only goal is to provide an affordable ultrasound method to accomplish this task.
It has been a year since my breast cancer diagnosis and I wanted to thank you for finding it with the automated full breast ultrasound.
I was an early adopter of automated full breast ultrasound. I have been using the SonoCiné system since 2005 and in our first 7000 studies in approximately 3000 women, I am proud to say that we detected over 30 hidden breast cancers with SonoCiné that could not be seen on mammograms.
We did 600 SonoCine exams and found four additional invasive ductal cancers that we couldn’t see on mammograms. So we know that we are finding breast cancers that we otherwise would not have been able to find if we weren’t using this technology in addition to screening mammography.
DOCTORS
- PATIENT CARE
Despite an annual spending of $ 7.8 billion on screening mammograms in the United States, more than 40,000 women die from breast cancer each year. Invasive breast cancer is the leading cause of death in this country for women between the ages of 35-54. According to the National Cancer Institute, in 2010, the cost of breast cancer treatment was approximately $ 16.5 billion in the United States, higher than any other type of cancer. This is expected to exceed $ 20.5 billion by 2020. Individual costs vary, depending on the stage of malignancy and the treatment options selected. Obviously, our current approach to the problem is inadequate.